Research Article
Analysis of the Distribution and Antibiotic Resistance of Pathogens Causing Infections in Hospitals from 2017 to 2019
Table 13
Analysis of multiple drug resistance rate of ESBLs-KPN in 2017.
| | Drugs | Drug resistance rate (%) |
| ESBLs-KPN | Ertapenem | 1.8 | | Imipenem | 2.8 | | Piperacillin-tazobactam | 8 | | Amikacin | 9.7 | | Cefoperazone-sulbactam | 21.7 | | Tobramycin | 27.8 | | Gentamicin | 40.9 | | Fosfomycin | 42.3 | | Nitrofurantoin | 48.3 | | Levofloxacin | 49.4 | | Cefepime | 50 | | Ciprofloxacin | 60.8 | | Ceftazidime | 63.1 | | Aztreonam | 73.9 | | Cotrimoxazole | 80.7 | | Ampicillin-sulbactam | 90.3 | | Ceftriaxone | 99.4 | | Ampicillin | 100 |
|
|